Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-06

Clinical Trial Update: A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese [Phase 1]

View source ↗

Summary

Phase 1 study results describe how danuglipron is taken up into the bloodstream and whether it influences the body's processing of atorvastatin and rosuvastatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danuglipron (danuglipron)
  • Rosuvastatin (rosuvastatin)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: COMPLETED